MDMA: fact and fallacy, and the need to increase knowledge in both the scientific and popular press.
Green
A Richard
AR
Neuropharmacology Research Group, School of Pharmacy, De Montfort University, The Gateway, Leicester, LE1 9BH, UK. richard.green@astrazeneca.com
D000818:Animals; D006213:Hallucinogens / Q000008:administration & dosage / Q000009:adverse effects*; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D013287:Illicit Drugs / Q000009:adverse effects; D018156:Journalism, Medical; D018817:N-Methyl-3,4-methylenedioxyamphetamine / Q000008:administration & dosage / Q000009:adverse effects*
D006213:Hallucinogens; D013287:Illicit Drugs; D018817:N-Methyl-3,4-methylenedioxyamphetamine